Uptake of genetic testing for infants with congenital heart disease: Impact of prenatal versus postnatal cardiovascular genetic counseling
Journal of Genetic Counseling · 2026-04 · 35 (2)
DOI: 10.1002/jgc4.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 03.04.2026. Verfasst von Rhea Rajan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Genetic Counseling, Heart Defects, Congenital, Genetic Testing, Prenatal Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Approximately 70% of congenital heart disease (CHD) is diagnosed through prenatal screening, allowing for early assessment and intervention. Expert consensus recommends genetic testing for apparently isolated CHD (iCHD), which can provide valuable insights into potential underlying genetic diagnoses. In the prenatal setting, parents may have access to non‐invasive screening options as well as diagnostic testing via amniocentesis. While some families may choose to decline amniocentesis, they may be more receptive to postnatal genetic testing as an alternative. Timing of genetic counseling (prenatal vs. postnatal) can affect parental decision‐making and genetic testing uptake. The primary aim of this study was to examine postnatal genetic testing uptake among families of infants with iCHD who received prenatal versus postnatal cardiovascular genetic counseling (CVGCing). We hypothesized that families of infants with iCHD who received prenatal CVGCing would have a higher uptake of postnatal genetic testing than those who received postnatal CVGCing. A retrospective chart review was completed for infants with iCHD admitted to the Cincinnati Children's Hospital Medical Center (CCHMC) Cardiac Intensive Care Unit (CICU) between January 1, 2019, and April 30, 2023. A total of 228 infants received CVGCing from a Cardiovascular Genetic Counselor (CVGC). Seventy‐six (33%) families received prenatal CVGCing and 152 (67%) were counseled postnatally. Patients receiving prenatal CVGCing were approximately four times more likely to consent for postnatal genetic testing (OR = 3.88, p = 0.03) than those who received postnatal CVGCing. Genetic testing confirmed a genetic diagnosis in 14% of infants. Positive genetic testing results included both copy number variants (70%) and single‐nucleotide variants (30%). In conclusion, families of infants with iCHD who received prenatal CVGCing were significantly more likely to consent for postnatal genetic testing. Patients receiving prenatal CVGCing were able to receive results faster, meet parental goals of earlier genetic counseling access, and increase genetic testing uptake. Although expert consensus statements often recommend chromosomal microarray as a first line of genetic testing for iCHD, the yield reported in our study supports consideration of CHD gene sequencing for all infants with iCHD. Preliminary results suggest prenatal CVGCing for iCHD, with consideration of comprehensive genetic testing including copy number variant analysis and gene sequencing, should be considered standard of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Rhea Rajan, James F Cnota, Nadine Kasparian, Cara Barnett, Erin M Miller, Amy Shikany
Zitieren
APA
Rajan, R., Cnota, J. F., Kasparian, N., Barnett, C., He, H., Weaver, K. N., Miller, E. M., & Shikany, A. (2026). Uptake of genetic testing for infants with congenital heart disease: Impact of prenatal versus postnatal cardiovascular genetic counseling. Journal of Genetic Counseling, 35(2). https://doi.org/10.1002/jgc4.70194
Vancouver
Rajan R, Cnota JF, Kasparian N, Barnett C, He H, Weaver KN, et al. Uptake of genetic testing for infants with congenital heart disease: Impact of prenatal versus postnatal cardiovascular genetic counseling. Journal of Genetic Counseling. 2026;35(2). doi:10.1002/jgc4.70194
BibTeX
@article{Rajan2026,
author = {Rajan, Rhea and Cnota, James F and Kasparian, Nadine and Barnett, Cara and He, Hua and Weaver, K Nicole and Miller, Erin M and Shikany, Amy},
title = {Uptake of genetic testing for infants with congenital heart disease: Impact of prenatal versus postnatal cardiovascular genetic counseling},
journal = {Journal of Genetic Counseling},
year = {2026},
volume = {35},
number = {2},
doi = {10.1002/jgc4.70194}
}
EUVIMED